Other languages Nuwellis, Inc.

Equities

NUWE

US67113Y4052

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
0.2523 ^USD	-8.09%		+40.17%	-56.57%

May. 07	Top Midday Gainers	MT
May. 07	Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Midday Gainers	May. 07
Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07
Nuwellis, Inc. Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology	May. 02
Nuwellis, Inc. Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health	Apr. 09
Nuwellis, Inc. Announces Results from Two New Clinical Data Analyses from the AVOID-HF Trial, Which Demonstrate the Benefits of its Aquadex System in Reducing Heart Failure Readmissions at 30 Days	Mar. 07
Nuwellis, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 06
Nuwellis Receives FDA Approval for Specialized Catheter	Jan. 04
Nuwellis, Inc. Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter	Jan. 04
Nuwellis, Inc. Announces New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring Foriatric Patients	Nov. 28
Nuwellis, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07
Nuwellis, Inc. Announces Board of Directors Transition	Nov. 01
Nuwellis Provides Regulatory Update on Seastar Medical's Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under A Humanitarian Device Exemption	23-10-10
Top Premarket Decliners	23-09-11
Nuwellis Unveils CFO Transition Plan	23-08-08
Nuwellis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08
Nuwellis Signs Supply, Collaboration Agreement With DaVita for Aquadex Ultrafiltration Therapy Pilot Program	23-06-20
Nuwellis, Inc. Announces the Appointment of Mike Mccormick to its Board of Directors	23-06-05
Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09
Nuwellis, Inc. Auditor Raises 'Going Concern' Doubt	23-03-02
Nuwellis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Nuwellis, Inc.

Equities

NUWE

US67113Y4052

Other languages

Filters